Eli Lilly and Co. is planning to construct an active pharmaceutical ingredients and pharmaceutical production campus on a 600-acre site at the LEAP Lebanon Innovation and Research District in the Lebanon area of Boone County. The project scope includes construction of multiple buildings totaling 700,000 sq ft to 800,000 sq ft; and purchase and installation of stainless steel piping, fume hoods, conveyors, wet laboratory, testing, air handling, sterilization, formulation, filling, finishing and assembly equipment and systems. Construction is expected to begin in February 2023. The estimated EPC cost is $2.1 billion. Eli Lilly is also planning to construct a genetic medicine research and development facility in Boston and a pharmaceutical product and device manufacturing, packaging and distribution facility in Concord, N.C. Eli Lilly and Co., 893 Delaware St., Indianapolis, 46225. IR#IN220523.